Table 2. Univariate and multivariate analysis of overall survival (OS) in hepatocellular carcinoma.
| Variables | n | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | ||
| Age (years) | |||||
| <50 | 44 | 0.791(0.455-1.374) | 0.405 | ||
| ≥50 | 57 | ||||
| Gender | |||||
| Female | 46 | 0.726(0.418-1.259) | 0.254 | ||
| Male | 55 | ||||
| Tumor size(cm) | |||||
| <5 | 44 | 0.576(0.330-1.006) | 0.053 | ||
| ≥5 | 57 | ||||
| Histologic grade | |||||
| Poor | 39 | 2.558(1.267-5.164) | 0.009 | 2.377(1.164-4.854) | 0.017 |
| Moderate | 32 | ||||
| Well | 30 | ||||
| Liver cirrhosis | |||||
| Absence | 36 | 0.792(0.440-1.425) | 0.437 | ||
| Presence | 65 | ||||
| Serum AFP (ng/ml) | |||||
| ≤400 | 35 | 0.914(0.524-1.594) | 0.752 | ||
| >400 | 66 | ||||
| BCLC stage | |||||
| A | 18 | 0.372(0.150-0.923) | 0.033 | 0.480(0.169-1.364) | 0.168 |
| B | 36 | ||||
| C | 47 | ||||
| HBV | |||||
| Negative | 11 | 0.377(0.117-1.212) | 0.102 | ||
| Positive | 90 | ||||
| Microvascular invasion | |||||
| NO | 54 | 0.546(0.316-0.942) | 0.030 | 0.617(0.338-1.124) | 0.115 |
| Yes | 47 | ||||
| IL-37 expression | |||||
| High | 51 | 0.496(0.285-0.863) | 0.013 | 0.555(0.308-0.999) | 0.050 |
| Low | 50 | ||||
AFP, α-fetoprotein;BCLC stage, Barcelona Clinic Liver Cancer stage;HBV, hepatitis B virus;